Cargando…
Effects of diabetes on the rebleeding rate following endoscopic treatment in patients with liver cirrhosis
In the present study, the effects of diabetes on rebleeding following endoscopic treatment were assessed in patients with liver cirrhosis. A retrospective analysis of patients who underwent endoscopic variceal ligation (EVL) or endoscopic injection sclerotherapy (EIS) at the First Affiliated Hospita...
Autores principales: | Wang, Xi, Mei, Xuecan, Kong, Derun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388417/ https://www.ncbi.nlm.nih.gov/pubmed/32742363 http://dx.doi.org/10.3892/etm.2020.8876 |
Ejemplares similares
-
Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020) -
Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016) -
Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding
por: Gao, Yanying, et al.
Publicado: (2022) -
Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis
por: Pfisterer, Nikolaus, et al.
Publicado: (2021) -
Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis
por: Li, Fenghui, et al.
Publicado: (2023)